South Korea's drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, Yonhap News Agency reported. The Ministry of Food and Drug Safety approved the use of the vaccine developed by the British-Swedish pharmaceutical giant and Oxford University following a final review meeting. The ministry approved AstraZeneca's two full-dose regimen on the condition that the pharmaceutical firm submit further data on the current phase three clinical trials on adults aged over 18.
